迈克生物：IVD产业链在A股上市的公司有七十余家

Core Viewpoint - The IVD industry chain is experiencing intensified competition in the A-share market, driven by national policies, with the company focusing on the research, production, sales, and related services of in vitro diagnostic products [1] Company Summary - The company has over 30 years of experience in the development of in vitro diagnostic devices, reagents, calibrators, and quality control products, establishing a systematic professional capability [1] - The company has completed the layout of the entire industry chain, from biological raw materials to medical laboratory products and specialized services [1] - The company is entering a development phase focused on building smart laboratories through automation and intelligent products [1] - The company aims to continuously enhance its domestic and international marketing network to increase market share and brand influence [1] Industry Summary - There are over 70 companies listed in the A-share market within the IVD industry chain, indicating a competitive landscape [1]